Needham & Company LLC reissued their buy rating on shares of CompoSecure (NASDAQ:CMPO – Free Report) in a research note published on Tuesday, Benzinga reports. They currently have a $15.00 price objective on the stock.
CMPO has been the subject of a number of other reports. Benchmark restated a buy rating and set a $8.00 price target on shares of CompoSecure in a research report on Wednesday, April 24th. B. Riley upped their target price on CompoSecure from $14.00 to $17.00 and gave the stock a buy rating in a research note on Thursday, March 7th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of Moderate Buy and a consensus target price of $12.17.
Get Our Latest Research Report on CompoSecure
CompoSecure Price Performance
CompoSecure (NASDAQ:CMPO – Get Free Report) last posted its earnings results on Wednesday, March 6th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. CompoSecure had a negative return on equity of 10.41% and a net margin of 4.82%. The business had revenue of $99.90 million during the quarter, compared to analyst estimates of $95.86 million. Sell-side analysts expect that CompoSecure will post 1.09 earnings per share for the current fiscal year.
CompoSecure Announces Dividend
The company also recently declared a dividend, which will be paid on Tuesday, June 11th. Shareholders of record on Monday, May 20th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, May 17th.
Institutional Investors Weigh In On CompoSecure
Several hedge funds have recently added to or reduced their stakes in CMPO. Allspring Global Investments Holdings LLC raised its holdings in shares of CompoSecure by 67.6% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 25,430 shares of the company’s stock valued at $164,000 after buying an additional 10,259 shares in the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new position in CompoSecure in the 3rd quarter worth $150,000. Steamboat Capital Partners LLC lifted its stake in CompoSecure by 1.9% in the third quarter. Steamboat Capital Partners LLC now owns 2,451,883 shares of the company’s stock worth $15,815,000 after purchasing an additional 45,501 shares during the last quarter. B. Riley Asset Management LLC boosted its position in CompoSecure by 264.9% during the third quarter. B. Riley Asset Management LLC now owns 248,927 shares of the company’s stock valued at $1,606,000 after buying an additional 180,705 shares during the period. Finally, Potomac Capital Management Inc. grew its stake in shares of CompoSecure by 169.0% during the third quarter. Potomac Capital Management Inc. now owns 440,715 shares of the company’s stock valued at $2,843,000 after buying an additional 276,890 shares during the last quarter. Institutional investors own 37.56% of the company’s stock.
About CompoSecure
CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.
Read More
- Five stocks we like better than CompoSecure
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Will the Biotech Sector Shift From Lagger to Leader?
- What Are Dividend Contenders? Investing in Dividend Contenders
- Robinhood Soars: Dissecting a Record-Breaking Q1 2024
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Plug Power is Building the Future of Hydrogen Despite Headwinds
Receive News & Ratings for CompoSecure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompoSecure and related companies with MarketBeat.com's FREE daily email newsletter.